FB49 is a selective Bcl-2-associated athanogene 3 (BAG3) inhibitor with a Ki of 45 µM. It inhibits the proliferation of human tumoral cells without affecting the viability of human peripheral mononuclear cells. Additionally, FB49 arrests the cell cycle at the G1 phase and induces apoptosis and autophagy in treated medulloblastoma HD-MB03 cells [1].
Molecular Weight:
378.4
Formula:
C17H18N2O6S
Target:
Autophagy|||Apoptosis
* VAT and and shipping costs not included. Errors and price changes excepted
